GSK goes deep with DPAc

GlaxoSmithKline plc's Discovery Partnerships with Academia program has struck new deals with laboratories at the Vanderbilt University School of Medicine and The Hospital for Sick Children to identify compounds for severe obesity and cystic fibrosis, respectively. The partnerships aim to re-examine previously known targets in light of new structural and functional insights.

Meanwhile, GSK has cast a broad net to draw in new academic partners through a call for proposals in which academics vie for an opportunity to conduct screens of their most promising targets with GSK's compounds at the pharma's screening facilities...